title: Phase II study of pirarubicin in untreated metastatic small cell lung carcinoma. Groupe Français de Pneumo-Cancérologie (GFPC)
authors.forename: J P
authors.initials: JP
authors.lastname: Kleisbauer
authors.forename: J
authors.initials: J
authors.lastname: Vergeret
authors.forename: P
authors.initials: P
authors.lastname: Balmes
authors.forename: M
authors.initials: M
authors.lastname: Reynaud-Gaubert
authors.forename: A
authors.initials: A
authors.lastname: Taytard
authors.forename: R
authors.initials: R
authors.lastname: Targhetta
authors.forename: P
authors.initials: P
authors.lastname: Thomas
authors.forename: F
authors.initials: F
authors.lastname: Bonnaud
authors.forename: R
authors.initials: R
authors.lastname: Poirier
mesh_terms: D018288:Carcinoma, Small Cell / Q000188:drug therapy* / Q000556:secondary; D004317:Doxorubicin / Q000031:analogs & derivatives* / Q000627:therapeutic use; D004341:Drug Evaluation; D008175:Lung Neoplasms / Q000188:drug therapy* / Q000556:secondary
chemical_list: D004317:Doxorubicin; C027260:pirarubicin